Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ABBVIE-INC-12136589/news/AbbVie-Risankizumab-Meets-All-Primary-Endpoints-Reporting-Positive-Results-in-Fourth-Pivotal-Phase-25611449/?utm_source=whatsapp&utm_medium=social&utm_campaign=share